Administering subcutaneous methotrexate for inflammatory arthritis
Rheumatology Forum
Skills development and training
- Tuesday, 12.45-13.45
- | The ACC 7
Come along to the launch of this updated RCN guidance. Originally published in April 2004, this new edition has been updated and developed for use by all health care professionals working within primary, secondary and tertiary care settings. It will aid practitioners in the safe and effective administration and use of licensed subcutaneous methotrexate injections for a number of rheumatological conditions. Providing the most current evidence, this new guidance covers aspects of both adult and child/young people’s care, as well as providing a framework to help patients and their carers to administer treatment at home.
Sponsored by
